| Justin Scherff, DPT | |
|
516 Nile Kinnick Dr S, Suite B, Adel, IA 50003-2076 | |
| (515) 993-5599 | |
| (515) 993-1964 |
| Full Name | Justin Scherff |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 10 Years |
| Location | 516 Nile Kinnick Dr S, Adel, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982016721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Core Physical Therapy Inc | 8123034436 | 17 |
News Archive
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.
Understanding population mobility patterns could hold the key to tackling malaria in the Amazon, say scientists. Malaria has traditionally been seen as a rural scourge, but increasingly it is being documented in or near urban areas, experts warn, as a new study shows that human mobility plays an important role in the "urbanization" of the disease.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
With use of synthetic opioid "designer drugs" on the rise, scientists from The Scripps Research Institute have a new strategy to curb addiction and even prevent fatal overdoses.
As anticipated, Almac's biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies and continued growth of its screening kits offering. Biocatalysis is increasingly recognised as an alternative solution for solving complex chemistry problems due to its rapid implementation, economic benefits and 'green' reputation.
› Verified 4 days ago
| Provider Name | Core Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609820133 PECOS PAC ID: 8123034436 Enrollment ID: O20060223000621 |
News Archive
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.
Understanding population mobility patterns could hold the key to tackling malaria in the Amazon, say scientists. Malaria has traditionally been seen as a rural scourge, but increasingly it is being documented in or near urban areas, experts warn, as a new study shows that human mobility plays an important role in the "urbanization" of the disease.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
With use of synthetic opioid "designer drugs" on the rise, scientists from The Scripps Research Institute have a new strategy to curb addiction and even prevent fatal overdoses.
As anticipated, Almac's biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies and continued growth of its screening kits offering. Biocatalysis is increasingly recognised as an alternative solution for solving complex chemistry problems due to its rapid implementation, economic benefits and 'green' reputation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Scherff, DPT 2001 Westown Pkwy, Suite 107, West Des Moines, IA 50265-1540 Ph: (515) 440-3439 | Justin Scherff, DPT 516 Nile Kinnick Dr S, Suite B, Adel, IA 50003-2076 Ph: (515) 993-5599 |
News Archive
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.
Understanding population mobility patterns could hold the key to tackling malaria in the Amazon, say scientists. Malaria has traditionally been seen as a rural scourge, but increasingly it is being documented in or near urban areas, experts warn, as a new study shows that human mobility plays an important role in the "urbanization" of the disease.
Ligand Pharmaceuticals Incorporated today announced that GlaxoSmithKline was granted marketing authorization from the European Commission for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).
With use of synthetic opioid "designer drugs" on the rise, scientists from The Scripps Research Institute have a new strategy to curb addiction and even prevent fatal overdoses.
As anticipated, Almac's biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies and continued growth of its screening kits offering. Biocatalysis is increasingly recognised as an alternative solution for solving complex chemistry problems due to its rapid implementation, economic benefits and 'green' reputation.
› Verified 4 days ago
Alicia J Fisher, PT DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 516 Nile Kinnick Dr S, Suite B, Adel, IA 50003 Phone: 515-993-5599 Fax: 515-993-1964 | |
Michael J Burggraaf, PT MS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 516 Nile Kinnick Dr. South, Ste B, Adel, IA 50003 Phone: 515-993-5599 Fax: 515-993-1964 | |
Dirk Swanson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 608 Greene St, Adel, IA 50003 Phone: 515-993-4596 | |
Robin Sue Mulvey, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 803 Cottage St, Adel, IA 50003 Phone: 515-993-5599 Fax: 515-993-1964 | |
Laura M Hejtmanek, PT DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 516 Nile Kinnick Dr. South, Ste B, Adel, IA 50003 Phone: 515-993-5599 Fax: 515-993-1964 | |
Maria Anne Dawley, Physical Therapist Medicare: Medicare Enrolled Practice Location: 817 Main St Ste A, Adel, IA 50003 Phone: 515-993-2170 | |
Memory Porter, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 817 Main St, Adel, IA 50003 Phone: 515-993-2170 Fax: 515-993-2174 |